Connecticut SB 188: AN ACT REQUIRING BRAND NAME PRESCRIPTION DRUG MANUFACTURERS TO PROVIDE SAMPLES OF BRAND NAME DRUGS TO GENERIC PRESCRIPTION DRUG MANUFACTURERS.

Status: REF. BY SEN. TO COMM. ON Judiciary (as of 2022-04-07)

State: Connecticut · Session: 2022 · Bill: SB 188

Subjects: Drug manufacturers, Drug wholesalers, Pharmaceutical industry, Unfair or deceptive trade practices

Sponsors: Anwar, Saud, Looney, Martin M., Winkler, Michael A.

View Connecticut SB 188 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.